Background Inhibitors of sodium-glucose co-transporter-2 (SGLT2i) were found to improve renal outcome in diabetic patients in large prospective randomized trials. Yet. SGLT2i may acutely reduce kidney function through volume depletion. altered glomerular hemodynamics or intensified medullary hypoxia leading to acute tubular injury (ATI). https://www.ealisboa.com/mega-deal-OtterBox-Defender-Case-for-Samsung-Galaxy-S23-Ultra-top-savings/